Constipation as an under-recognized symptom burden in peritoneal dialysis patients: a systematic review
Review of Clinical Pharmacology and Pharmacokinetics · 20.11.2026 · 40 · 99-117
DOI: 10.61873/rcpp.40.e205330 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Review of Clinical Pharmacology and Pharmacokinetics, online erschienen am 20.11.2026. Verfasst von Sotiroulla Konstantinou Glyky und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Constipation and bowel dysfunction are clinically relevant concerns in patients receiving peritoneal dialysis (PD), but reported prevalence varies because of differences in definitions, assessment methods, and study populations.
Aim
To synthesize evidence on constipation and bowel dysfunction in adults receiving PD, including prevalence, assessment, symptom burden, quality of life, clinical outcomes, and management interventions. Methodology: A systematic review with narrative synthesis was conducted with PRISMA 2020 used as the reporting framework. Primary quantitative, qualitative, and mixed-methods studies providing directly extractable constipation- or bowel-function-specific PD data were eligible. Methodological quality was assessed using design-specific Joanna Briggs Institute critical appraisal tools.
Results
Twenty-eight primary empirical studies published between 2002 and 2026 were included. All included studies used quantitative observational or interventional designs; no eligible qualitative or mixed-methods studies were identified. Reported constipation prevalence ranged from 13% to 77.4%. Observational studies associated constipation and gastrointestinal symptom burden with poorer quality of life, while prospective evidence identified associations with clinically relevant outcomes, including peritonitis. Interventional studies evaluated dietary, pharmacological, prebiotic, probiotic, synbiotic, and other approaches, with improvements in selected outcomes; however, heterogeneity precluded conclusions regarding comparative effectiveness.
Conclusion
Constipation and bowel dysfunction are clinically relevant in PD. Standardized multidimensional assessment and individualized management are warranted, while adequately powered prospective and randomized studies using consistent outcomes and patient-reported measures are needed.
Zitieren
APA
Glyky, S. K., Noula, M., Frangou, E., & Roupa, Z. (2026). Constipation as an under-recognized symptom burden in peritoneal dialysis patients: a systematic review. Review of Clinical Pharmacology and Pharmacokinetics, 40, 99-117. https://doi.org/10.61873/rcpp.40.e205330
Vancouver
Glyky SK, Noula M, Frangou E, Roupa Z. Constipation as an under-recognized symptom burden in peritoneal dialysis patients: a systematic review. Review of Clinical Pharmacology and Pharmacokinetics. 2026;40:99-117. doi:10.61873/rcpp.40.e205330
BibTeX
@article{Glyky2026,
author = {Glyky, Sotiroulla Konstantinou and Noula, Maria and Frangou, Eleni and Roupa, Zoe},
title = {Constipation as an under-recognized symptom burden in peritoneal dialysis patients: a systematic review},
journal = {Review of Clinical Pharmacology and Pharmacokinetics},
year = {2026},
volume = {40},
pages = {99--117},
doi = {10.61873/rcpp.40.e205330}
}
EUVIMED